Plant Comparison
Boswellia vs Japanese knotweed
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Boswellia and Japanese knotweed: they share 4 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Boswellia | Japanese knotweed | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 9/10 | 2/10 | Stronger for Boswellia |
| Cancer (anticancer research) | 7/10 | 2/10 | Stronger for Boswellia |
| Inflammation (general) | 5/10 | 7/10 | Stronger for Japanese knotweed |
| Skin irritation | 5/10 | 1/10 | Stronger for Boswellia |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal anti-inflammatory compounds; AKBA inhibits 5-lipoxygenase. Absorption improves when taken with a high-fat meal.
Additional constituents of the oleo-gum-resin.
Considered the principal bioactive constituents, responsible for much of the antioxidant, anti-inflammatory and cardioprotective activity attributed to this root.
Emodin has laxative and anti-inflammatory activity at typical concentrations but can cause gastrointestinal upset at high doses.
Pharmacological Actions
Anti-inflammatory (inhibits 5-lipoxygenase / leukotriene synthesis and NF-kB signalling); Reduces inflammatory markers (e.g. hs-CRP) and, in one RCT, improved knee joint-space and reduced osteophytes on radiograph
Boswellic acids, especially acetyl-11-keto-beta-boswellic acid (AKBA) from Boswellia serrata, induce cell-cycle arrest and apoptosis and inhibit proliferation, invasion and metastasis across lung, colorectal and prostate cancers (preclinical, incl. in vivo).
Traditional & Indicated Uses
Osteoarthritis: reduces joint pain and stiffness and improves function (over at least 4 weeks); Supports inflammatory arthritis including rheumatoid arthritis
Boswellia serrata resin and its triterpenoid AKBA arrest the cell cycle and induce apoptosis in non-small-cell lung cancer, suppress colitis-associated colorectal cancer (NF-kB, gut microbiota) and inhibit prostate cancer (IL-17 pathway) in vitro and in vivo (preclinical).
Supportive in inflammatory bowel disease (ulcerative colitis, Crohn's disease)
inferred from anti-inflammatory action
Analgesic (pain relief); Osteoarthritis: reduces joint pain and stiffness and improves function (over at least 4 weeks)
inferred from anti-inflammatory action
inferred from anticancer action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally well tolerated; the most commonly reported side effects are mild gastrointestinal symptoms, and allergic reactions are rare.
Boswellic acids can affect drug-metabolising enzymes, so caution is advised when taking other medicines; safety in pregnancy and breastfeeding is not established, so avoid medicinal doses.
Japanese knotweed root contains resveratrol and emodin; high doses of emodin may cause GI discomfort and have laxative effects. Not recommended during pregnancy (emodin has potential teratogenic effects in animal studies). May interact with anticoagulants and antiplatelet medications. Quality control of commercial preparations is important as invasive weed extracts vary significantly.
Duke (2002) rates Japanese knotweed (listed as Hu-Zhang, Fallopia japonica) as +++ and highlights its rich content of resveratrol and emodin. Experimental evidence (score 1) supports COX-2 inhibitory, antioxidant, anti-inflammatory, hepatoprotective, and lipid-lowering activities — largely attributed to resveratrol. Duke notes its use in traditional Chinese medicine for fractures, burns, abscesses, and gynecological conditions. No significant clinical trials were available at time of publication, but resveratrol's biological activity is well-documented in vitro (Duke, 2002).
External Ids
Botanical Description
Small to medium deciduous tree with thin, papery, peeling bark. The leaves are pinnately compound with numerous small, toothed leaflets, clustered toward the branch tips. Small, pale yellow to white flowers are borne in axillary racemes. When the bark is cut, it exudes a fragrant, resinous gum (oleo-gum-resin) that hardens into pale, waxy tears - the medicinal part.[12]
Vigorous, invasive rhizomatous perennial (Polygonaceae) with hollow, bamboo-like, jointed stems 1-3 m tall (occasionally taller), speckled reddish-purple. Leaves are broad, heart- to shovel-shaped with a flat base. Abundant sprays of small, creamy-white flowers appear in late summer, followed by small winged fruit.[6]
Habitat
Native to dry, rocky, hilly terrain of India and parts of the Middle East and North Africa, where it is tapped for its resin much like frankincense (Boswellia sacra).[12]
Native to East Asia (Japan, China, Korea), now a notorious invasive species across Europe and North America, growing in disturbed ground, riverbanks, roadsides and waste land, spreading aggressively via an extensive rhizome network.[6]
Harvesting
The bark is deliberately incised and the exuded oleo-gum-resin is allowed to harden and is collected over several days to weeks, then cleaned and graded before use or extraction.[12]
The rhizome/root, the main medicinal part, is dug in autumn or winter when resveratrol content is highest; young spring shoots (stems) are also edible and used. Strict containment is required when harvesting, given the plant's severe invasiveness.[6]
Traditional Uses
Boswellia resin (salai guggul) is a mainstay of Ayurvedic medicine for inflammatory joint and respiratory conditions, and has been burned as incense across many cultures. Modern standardised extracts, rich in boswellic acids, are used for osteoarthritis, inflammatory bowel disease and other inflammatory conditions, directly building on this traditional anti-inflammatory reputation.[12]
Known as Hu Zhang in Traditional Chinese Medicine, Japanese knotweed root has a centuries-old use for inflammation, infections, jaundice and menstrual complaints. Modern interest centres on its resveratrol and emodin content, now studied (as Polygonum cuspidatum extract) for antioxidant, anti-inflammatory, cardioprotective and hepatoprotective activity, and more recently for supportive use in acute respiratory infections.[2, 3, 6]
Preparations
Resin extract standardised to boswellic acid (often AKBA) content, taken as capsules or tablets, ideally with a fat-containing meal to aid absorption.
Dosage
Clinical trials in osteoarthritis commonly use extracts providing around 100-250 mg of boswellic acids (or several hundred mg of standardised extract) daily, in divided doses, taken with food. Educational reference only, not a prescription.
Duke (2002) and general phytotherapy guidance treat this as an experimentally supported herb without a single agreed clinical dose; commercial resveratrol-standardised extracts should be dosed per product labelling. Educational reference only, not a prescription; avoid in pregnancy.
References
Lookalikes Review
References & Sources
- Siddiqui, M.Z (2011) 'Boswellia serrata, a potential antiinflammatory agent: an overview', Indian Journal of Pharmaceutical Sciences, 73(3), pp. 255-261. doi:10.4103/0250-474X.93507 Meta-analysis / review
https://doi.org/10.4103/0250-474X.93507 - Majeed, M., Majeed, S., Narayanan, N.K. and Nagabhushanam, K (2019) 'A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee', Phytotherapy Research, 33(5), pp. 1457--1468. doi:10.1002/ptr.6338 Randomized trial
https://doi.org/10.1002/ptr.6338 - Karlapudi, V., Sunkara, K.B., Konda, P.R., Sarma, K.V. and Rokkam, M.P (2022) 'Efficacy and Safety of Aflapin, a Novel Boswellia serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study', Journal of the American Nutrition Association, 42(2), pp. 159-168. doi:10.1080/07315724.2021.2014370 Randomized trial
https://doi.org/10.1080/07315724.2021.2014370 - Kirste, S., Treier, M., Wehrle, S.J., Becker, G., Abdel-Tawab, M., Gerbeth, K., Hug, M.J., Lubrich, B., Grosu, A.L. and Momm, F (2011) 'Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial', Cancer, 117(16), pp. 3788-3795. doi:10.1002/cncr.25945 Randomized trial
https://doi.org/10.1002/cncr.25945 - Abdel-Tawab, M., Werz, O. and Schubert-Zsilavecz, M (2011) 'Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data', Clinical Pharmacokinetics, 50(6), pp. 349-369. doi:10.2165/11586800-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11586800-000000000-00000 - Gomaa, A.A., Mohamed, H.S., Abd-Ellatief, R.B. and Gomaa, M.A (2021) 'Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly', Inflammopharmacology, 29(4), pp. 1033-1048. doi:10.1007/s10787-021-00841-8 Meta-analysis / review
https://doi.org/10.1007/s10787-021-00841-8 - Khan, M.A., Ali, R., Parveen, R., Najmi, A.K. and Ahmad, S (2016) 'Pharmacological evidences for cytotoxic and antitumor properties of Boswellic acids from Boswellia serrata', Journal of Ethnopharmacology, 191, pp. 315-323. doi:10.1016/j.jep.2016.06.053 Meta-analysis / review
https://doi.org/10.1016/j.jep.2016.06.053 - Ammon, H.P.T (2010) 'Modulation of the immune system by Boswellia serrata extracts and boswellic acids', Phytomedicine, 17(11), pp. 862-867. doi:10.1016/j.phymed.2010.03.003 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2010.03.003 - Alluri, V.K., Kundimi, S., Sengupta, K., Golakoti, T. and Kilari, E.K (2020) 'An Anti-Inflammatory Composition of Boswellia serrata Resin Extracts Alleviates Pain and Protects Cartilage in Monoiodoacetate-Induced Osteoarthritis in Rats', Evidence-Based Complementary and Alternative Medicine, 2020, pp. 7381625. doi:10.1155/2020/7381625 Preclinical
https://doi.org/10.1155/2020/7381625 - Henrotin, Y., Dierckxsens, Y., Delisse, G., Maes, N. and Albert, A (2022) 'Curcuma and Boswellia serrata extract combination for hand osteoarthritis: an open-label pre-post trial', Pharmaceutical Biology, 60(1), pp. 2295-2299. doi:10.1080/13880209.2022.2147550 Clinical study
https://doi.org/10.1080/13880209.2022.2147550 - Cherepanova, M.O. and Subotyalov, M.A (2023) 'Component Composition and Biological Activity of Oleo-Gum Resin from Boswellia serrata (Burseraceae)', Doklady Biological Sciences, 512(1), pp. 336-342. doi:10.1134/S0012496623700643 Meta-analysis / review
https://doi.org/10.1134/S0012496623700643 - Ammon, H.P.T (2016) 'Boswellic Acids and Their Role in Chronic Inflammatory Diseases', Advances in Experimental Medicine and Biology. doi:10.1007/978-3-319-41334-1_13 Preclinical
https://doi.org/10.1007/978-3-319-41334-1_13 - Yu, G., Xiang, W., Zhang, T., Zeng, L., Yang, K. and Li, J (2020) 'Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis', BMC Complementary Medicine and Therapies. doi:10.1186/s12906-020-02985-6 Meta-analysis / review
https://doi.org/10.1186/s12906-020-02985-6 - Lv, M. and Shao, S. and Zhang, Q. and Zhuang, X. and Qiao, T (2020) 'Acetyl-11-Keto-beta-Boswellic Acid Exerts the Anti-Cancer Effects via Cell Cycle Arrest, Apoptosis Induction and Autophagy Suppression in Non-Small Cell Lung Cancer Cells', OncoTargets and Therapy, 13, pp. 733-744. doi:10.2147/OTT.S236346 Preclinical
https://doi.org/10.2147/OTT.S236346 - Xu, F. and Li, W. and Zheng, X.-J. and Hao, Y. and Yang, Y.-H. and Yang, H. and Zhang, S. and Cao, W.-X. and Li, X.-X. and Zhang, X. and Du, G.-H. and Ji, T.-F. and Wang, J.-H (2025) '3-O-Acetyl-11-Keto-beta-Boswellic Acid Suppresses Colitis-Associated Colorectal Cancer by Inhibiting the NF-kB Signaling Pathway and Remodeling Gut Microbiota', Oncology Research, 33(8), pp. 1969-1989. doi:10.32604/or.2025.062386 Preclinical
https://doi.org/10.32604/or.2025.062386 - Zou, B. and Liu, Q. and Long, Y. and Dai, X. and Tian, X. and Zhou, Q (2025) 'Network Pharmacology Combined with Proteomics Reveals That 3-Acetyl-11-keto-beta-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway', ACS Omega, 10(21), pp. 21813-21822. doi:10.1021/acsomega.5c01683 Preclinical
https://doi.org/10.1021/acsomega.5c01683 - Ragab, E.A. and Abd El-Wahab, M.F. and Doghish, A.S. and Salama, R.M. and Eissa, N. and Darwish, S.F (2023) 'The journey of boswellic acids from synthesis to pharmacological activities', Naunyn-Schmiedeberg's Archives of Pharmacology, 397(3), pp. 1477-1504. doi:10.1007/s00210-023-02725-w Preclinical
https://doi.org/10.1007/s00210-023-02725-w - Liu, X., Machado, G.C., Eyles, J.P., Ravi, V. and Hunter, D.J (2018) 'Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis', British Journal of Sports Medicine, 52(3), pp. 167--175. doi:10.1136/bjsports-2016-097333 Meta-analysis / review
https://doi.org/10.1136/bjsports-2016-097333
- Dong, X., Fu, J., Yin, X., Cao, S. and others (2016) 'Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics', Phytotherapy Research, 30(8), pp. 1207-1218. doi:10.1002/ptr.5631 Traditional / reference
https://doi.org/10.1002/ptr.5631 - Wang, S., Yang, Y., Sun, L., Qiao, G. and others (2022) 'Reynoutria japonica Houtt for Acute Respiratory Tract Infections in Adults and Children: A Systematic Review', Frontiers in Pharmacology, 13, pp. 787032. doi:10.3389/fphar.2022.787032 Meta-analysis / review
https://doi.org/10.3389/fphar.2022.787032 - Ke, Y., Zhan, L., Lu, T., Zhou, C. and others (2023) 'Advances for pharmacological activities of Polygonum cuspidatum (Reynoutria japonica) - A review', Pharmaceutical Biology, 61(1), pp. 177-188. doi:10.1080/13880209.2022.2158349 Traditional / reference
https://doi.org/10.1080/13880209.2022.2158349 - Zhang, Q., Zhao, Y., Zhang, M., Zhang, Y. and others (2021) 'Bioactive amides from Reynoutria japonica', Journal of Asian Natural Products Research, 23(3), pp. 228-234. doi:10.1080/10286020.2021.1873298 Preclinical
https://doi.org/10.1080/10286020.2021.1873298 - Lai, Y., Zhou, C., Huang, P., Dong, Z. and others (2024) 'Polygonum cuspidatum polysaccharide: A review of its extraction and purification, structure analysis, and biological activity', Journal of Ethnopharmacology, 331, pp. 118079. doi:10.1016/j.jep.2024.118079 Traditional / reference
https://doi.org/10.1016/j.jep.2024.118079 - Peng, W., Qin, R., Li, X. and Zhou, H (2013) 'Botany, phytochemistry, pharmacology, and potential application of Polygonum cuspidatum Sieb. et Zucc.: a review', Journal of Ethnopharmacology, 148(3), pp. 729-745. doi:10.1016/j.jep.2013.05.007 Traditional / reference
https://doi.org/10.1016/j.jep.2013.05.007 - Wang, X., Liang, L., Yan, J., Li, Z. and others (2023) 'Citri Reticulatae Pericarpium-Reynoutria japonica Houtt. herb pair suppresses breast cancer liver metastasis by targeting ECM1-mediated cholesterol biosynthesis pathway', Phytomedicine, 116, pp. 154896. doi:10.1016/j.phymed.2023.154896 Preclinical
https://doi.org/10.1016/j.phymed.2023.154896 - Jiang, Y., Liu, Y., Zhang, X. and others (2020) 'New phenolic glycosides from Reynoutria japonica', Journal of Asian Natural Products Research, 22(1), pp. 17-23. doi:10.1080/10286020.2019.1646730 Preclinical
https://doi.org/10.1080/10286020.2019.1646730 - Liu, Y., Wang, J., Li, Q. and others (2024) 'The Possibility of Polygonum cuspidatum against Osteoarthritis based on Network Pharmacology', Current Computer-Aided Drug Design, 20(2), pp. 121-133. doi:10.2174/1573409919666230403114131 Preclinical
https://doi.org/10.2174/1573409919666230403114131 - Espinosa-Andrews, H., Morales-Hernandez, N., Garcia-Marquez, E. and others (2025) 'Physicochemical and rheological characteristics of commercial Greek-style yogurt enriched with Polygonum cuspidatum roots or the P. cuspidatum beta-cyclodextrin inclusion complex', Food Research International, 203, pp. 115854. doi:10.1016/j.foodres.2025.115854 Preclinical
https://doi.org/10.1016/j.foodres.2025.115854 - Burns, J., Yokota, T., Ashihara, H., Lean, M.E.J. and Crozier, A (2002) 'Plant foods and herbal sources of resveratrol', 50(11), pp. 3337--3340. doi:10.1021/jf0112973 Traditional / reference
https://doi.org/10.1021/jf0112973 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - World Health Organization (2007) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.